MPI researchers develop homogeneous hydrogenolysis reaction with molecular palladium catalyst
The new tritiation reaction is practical and robust to execute and could have an immediate impact in the discovery and development of pharmaceuticals.
Photo: Frank Vinken / MPI für Kohlenforschung
New method enables simple tritium labeling and could provide added value to the discovery and development of pharmaceuticals. The new tritiation reaction is practical and robust to execute and could have an immediate impact in the discovery and development of pharmaceuticals.
Tritium 3H, a radioactive isotope of hydrogen, is commonly used in medicinal chemistry as a label to follow the course of a drug in the human body. Chemists like to use the technique to evaluate drug candidates and their metabolism. However, synthesis of the radiolabeled molecules is challenging.
A team led by Professor Tobias Ritter of the Department of Organic Synthesis at the Max-Planck-Institut für Kohlenforschung has now found a new way to label complex small molecules with tritium. In a joint research project with the development department of the Swiss pharmaceutical company Roche, they investigated ways to incorporate tritium into pharmaceuticals and other similar molecules that may be important derivatives for the drug industry.
The team took advantage of the special properties of arylthianthrenium salts that they developed two years ago. The thianthrene group can be introduced into pharmaceuticals selectively and at a late stage in a direct and predictable manner. “The unusual feature of this work is the reaction of arylpseudohalides with hydrogen, catalyzed for the first time by a homogeneous catalyst,” explains Tobias Ritter. “Such reaction were previously unknown with conventional groups that can be introduced into pharmaceuticals. Normally, chemists use heterogeneous catalysts but those also often destroy other functional groups, which are frequently found in pharmaceuticals,” the director annotates.
The new approach does not require an inert atmosphere or dry conditions, making it practical to use.
The researchers present their research results in the leading scientific journal Nature.
Wissenschaftliche Ansprechpartner:
Prof. Dr. Tobias Ritter, Director of the Department of Organic Synthesis at the Max-Planck-Institut für Kohlenforschung, 0208-306-2414
Originalpublikation:
Title: Tritiation of aryl thianthrenium salts with a molecular palladium catalyst
Link: https://www.nature.com/articles/s41586-021-04007-y
Authors: Da Zhao, Roland Petzold, Jiyao Yan, Dieter Muri & Tobias Ritter
Media Contact
All latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
Microscopic basis of a new form of quantum magnetism
Not all magnets are the same. When we think of magnetism, we often think of magnets that stick to a refrigerator’s door. For these types of magnets, the electronic interactions…
An epigenome editing toolkit to dissect the mechanisms of gene regulation
A study from the Hackett group at EMBL Rome led to the development of a powerful epigenetic editing technology, which unlocks the ability to precisely program chromatin modifications. Understanding how…
NASA selects UF mission to better track the Earth’s water and ice
NASA has selected a team of University of Florida aerospace engineers to pursue a groundbreaking $12 million mission aimed at improving the way we track changes in Earth’s structures, such…
